1SXP — SCHOTT Pharma AG & Co KgaA Balance Sheet
0.000.00%
Last trade - 00:00
- €4.68bn
- €4.75bn
- €898.60m
- 56
- 10
- 41
- 25
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | — | — | — | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 19.3 | 28.2 | 30.6 | 28.4 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 153 | 187 | 385 | 285 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 239 | 302 | 555 | 468 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 267 | 334 | 517 | 638 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 596 | 740 | 1,197 | 1,232 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 210 | 244 | 323 | 351 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Funded Status | ||||
Total Liabilities | 281 | 322 | 489 | 541 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 315 | 418 | 707 | 690 |
Total Liabilities & Shareholders' Equity | 596 | 740 | 1,197 | 1,232 |
Total Common Shares Outstanding |